|Articles|January 2, 2010
- Pharmaceutical Technology-01-02-2010
- Volume 34
- Issue 1
Pharmaceutical Technology North America, January 2010 (PDF)
Quality by Design, Deficiencies in Generic Drug Applications, API Growth, Topical Berberine-Hydrochloride Products
Advertisement
Articles in this issue
almost 16 years ago
Understanding Biological Indicator Grow-Out Timesalmost 16 years ago
The Formulation and Evaluation of Topical Berberine-Hydrochloride Productsalmost 16 years ago
Healthcare Reform Requires Room for Innovationalmost 16 years ago
Pharma Faces Multiple Challenges in the Year Aheadalmost 16 years ago
A Look Ahead for 2010almost 16 years ago
In the Field: Report from Brazilalmost 16 years ago
GSK Gets under Your Skinalmost 16 years ago
Tracking API Growthalmost 16 years ago
Statistical Solutions: %RSD: Friend or Foe?Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
2
PharmTech Weekly News Roundup – Week of November 3, 2025
3
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
4
How AI, Machine Learning, and Large Language Models Enhance Bioanalysis
5
